Apitoria Pharma Private Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LOSARTAN POTASSIUM USP DRUG SUBSTANCE, with a corresponding US DMF Number 19671.
Remarkably, this DMF maintains an Active status since its submission on August 05, 2006, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 21, 2013, and payment made on September 13, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II